Medtech Acquisition Corp.-CWTLSIWPreferred / convertible
13F holders, Q1 2026 (March 31)7holders −1
1new positions
2sold out
1famous investor
$1.20avg. 13F price*
At the end of Q1 2026, 7 institutions reported holding Medtech Acquisition Corp.-CW (TLSIW) in their 13F filings, down 1 from Q4 2025. 1 opened new positions and 2 sold out. The largest holders were Cerity Partners LLC ($993K), Vestcor Inc ($85K) and Citadel Advisors ($78K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Medtech Acquisition Corp.-CW
- Filed as
- TRISALUS LIFE SCIENCES INC (Q1 2026)
- CUSIP
- 89680M119
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $60 |
| Exits | 2 | $53K |
All 13F filers, Q4 2025 → Q1 2026: 600 shares bought and 45,192 shares sold, net −44,592 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Cerity Partners LLC | — | No change | 827,590 | $993K |
| Vestcor Inc | — | No change | 70,832 | $85K |
| Citadel Advisors | — | Reduce -16.7% | 65,190 | $78K |
| Aristeia Capital, L.L.C. | — | Add +2.0% | 28,616 | $36K |
| Fort Baker Capital Management LP | — | Reduce -0.4% | 26,374 | $32K |
| Toronto Dominion Bank | — | No change | 5,170 | $6K |
| Rockefeller Capital Management L.P. | — | New | 50 | $60 |
"% of holder's portfolio" is TLSIW's weight in each manager's 13F, not the share of Medtech Acquisition Corp.-CW the manager owns.